Advisors Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.6M | Buy |
7,107
+385
| +6% | +$95.9K | 0.03% | 668 |
|
|
2025
Q4 | $1.62M | Buy |
6,722
+3,247
| +93% | +$830K | 0.03% | 661 |
|
|
2025
Q3 | $951K | Buy |
3,475
+561
| +19% | +$153K | 0.02% | 804 |
|
|
2025
Q2 | $752K | Buy |
2,914
+1,465
| +101% | +$349K | 0.01% | 857 |
|
|
2025
Q1 | $324K | Buy |
1,449
+300
| +26% | +$70K | 0.01% | 1026 |
|
|
2024
Q4 | $263K | Buy |
+1,149
| New | +$277K | ﹤0.01% | 1072 |
|
|
2023
Q4 | – | Sell |
-2,946
| Closed | -$436K | – | 1438 |
|
|
2023
Q3 | $436K | Sell |
2,946
-52
| -2% | -$9.4K | 0.01% | 934 |
|
|
2023
Q2 | $655K | Sell |
2,998
-2,826
| -49% | -$630K | 0.01% | 869 |
|
|
2023
Q1 | $1.28M | Sell |
5,824
-146
| -2% | -$31.7K | 0.03% | 675 |
|
|
2022
Q4 | $1.24M | Sell |
5,970
-4,708
| -44% | -$1.03M | 0.03% | 663 |
|
|
2022
Q3 | $2.33M | Sell |
10,678
-243
| -2% | -$55.3K | 0.05% | 449 |
|
|
2022
Q2 | $2.29M | Sell |
10,921
-4,399
| -29% | -$937K | 0.04% | 470 |
|
|
2022
Q1 | $3.71M | Sell |
15,320
-202
| -1% | -$48.9K | 0.06% | 363 |
|
|
2021
Q4 | $4.04M | Buy |
15,522
+158
| +1% | +$41K | 0.06% | 363 |
|
|
2021
Q3 | $4.05M | Sell |
15,364
-363
| -2% | -$99.3K | 0.06% | 335 |
|
|
2021
Q2 | $3.88M | Sell |
15,727
-6,089
| -28% | -$1.28M | 0.06% | 344 |
|
|
2021
Q1 | $4.23M | Buy |
21,816
+2,253
| +12% | +$452K | 0.07% | 305 |
|
|
2020
Q4 | $4.16M | Sell |
19,563
-1,518
| -7% | -$303K | 0.07% | 286 |
|
|
2020
Q3 | $3.61M | Sell |
21,081
-2,095
| -9% | -$387K | 0.07% | 276 |
|
|
2020
Q2 | $4.45M | Buy |
23,176
+1,271
| +6% | +$208K | 0.09% | 226 |
|
|
2020
Q1 | $3.23M | Buy |
21,905
+2,441
| +13% | +$389K | 0.08% | 264 |
|
|
2019
Q4 | $3.02M | Sell |
19,464
-2,119
| -10% | -$305K | 0.05% | 395 |
|
|
2019
Q3 | $2.92M | Sell |
21,583
-1,435
| -6% | -$188K | 0.05% | 400 |
|
|
2019
Q2 | $2.81M | Sell |
23,018
-5,497
| -19% | -$609K | 0.05% | 429 |
|
|
2019
Q1 | $2.96M | Sell |
28,515
-7,020
| -20% | -$725K | 0.05% | 407 |
|
|
2018
Q4 | $4.05M | Buy |
35,535
+2,160
| +6% | +$231K | 0.08% | 290 |
|
|
2018
Q3 | $3.85M | Sell |
33,375
-4,232
| -11% | -$464K | 0.06% | 360 |
|
|
2018
Q2 | $3.9M | Sell |
37,607
-12,077
| -24% | -$1.22M | 0.07% | 359 |
|
|
2018
Q1 | $4.73M | Sell |
49,684
-8,979
| -15% | -$848K | 0.08% | 333 |
|
|
2017
Q4 | $4.97M | Sell |
58,663
-14,593
| -20% | -$1.21M | 0.08% | 321 |
|
|
2017
Q3 | $5.64M | Buy |
73,256
+131
| +0.2% | +$10K | 0.09% | 293 |
|
|
2017
Q2 | $5.69M | Sell |
73,125
-541
| -0.7% | -$38.7K | 0.1% | 289 |
|
|
2017
Q1 | $5.3M | Buy |
73,666
+406
| +0.6% | +$28.1K | 0.09% | 318 |
|
|
2016
Q4 | $4.55M | Buy |
73,260
+2,284
| +3% | +$140K | 0.08% | 366 |
|
|
2016
Q3 | $4.6M | Buy |
70,976
+15,919
| +29% | +$1.06M | 0.08% | 377 |
|
|
2016
Q2 | $3.48M | Buy |
55,057
+19,256
| +54% | +$1.14M | 0.06% | 471 |
|
|
2016
Q1 | $2.07M | Buy |
35,801
+14,923
| +71% | +$845K | 0.03% | 626 |
|
|
2015
Q4 | $1.12M | Buy |
20,878
+16,436
| +370% | +$926K | 0.02% | 864 |
|
|
2015
Q3 | $226K | Sell |
4,442
-3,006
| -40% | -$162K | ﹤0.01% | 1336 |
|
|
2015
Q2 | $420K | Sell |
7,448
-250
| -3% | -$15.8K | 0.01% | 1181 |
|
|
2015
Q1 | $553K | Sell |
7,698
-10,736
| -58% | -$697K | 0.01% | 1060 |
|
|
2014
Q4 | $1.03M | Sell |
18,434
-5,068
| -22% | -$265K | 0.01% | 832 |
|
|
2014
Q3 | $1.16M | Sell |
23,502
-10,357
| -31% | -$527K | 0.02% | 772 |
|
|
2014
Q2 | $1.72M | Sell |
33,859
-6,153
| -15% | -$305K | 0.02% | 645 |
|
|
2014
Q1 | $1.79M | Sell |
40,012
-3,752
| -9% | -$169K | 0.03% | 581 |
|
|
2013
Q4 | $2.06M | Buy |
43,764
+4,137
| +10% | +$209K | 0.03% | 501 |
|
|
2013
Q3 | $2.09M | Buy |
39,627
+4,572
| +13% | +$222K | 0.04% | 473 |
|
|
2013
Q2 | $1.58M | Buy |
+35,055
| New | +$1.66M | 0.03% | 517 |
|
Other funds holding RMD
VCM
VPM
DAM
Advisors Asset Management's RMD Position: Q1 2026 in Review
Advisors Asset Management increased its ResMed (RMD) stake by 5.7% in Q1 2026, buying an estimated $95.9K and bringing the position to 7,107 shares worth $1.6M. The position accounts for 0.03% of the portfolio, ranked #668.
Advisors Asset Management first reported a position in RMD in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.69M in Q2 2017. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Advisors Asset Management held 7,107 shares of ResMed worth $1.6M as of Q1 2026.
- Advisors Asset Management bought 385 ResMed shares in Q1 2026, an estimated $95.9K.
- ResMed made up 0.03% of Advisors Asset Management's portfolio in Q1 2026, its #668 holding.
- Advisors Asset Management first reported a position in ResMed in Q2 2013 and has held it in 48 quarters since.
- Advisors Asset Management's ResMed position peaked at $5.69M in Q2 2017.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.